In contrast, GBM cells maintained in Neurobasal medium supplemented with EGF/FGF-2 retained the same proliferation capacity, migration/invasion histological features, genotype and gene expression profile of the tumors from which they were obtained. This evidence concerns the gene FGF2 and glioblastoma.